Mid cap
India Ratings lifts Marksans Pharma outlook to Positive
The rating agency affirmed the bank loan rating at IND AA- but moved the outlook to Positive, citing strong cash generation.
Embassy Developments promoter frees ₹117 cr in pledged shares
A promoter group entity has released a pledge on 2 crore shares, a modest reduction in encumbered holdings disclosed months after the fact.
MMTC's finance director and an independent director are set to leave
The two board members will exit after their terms expire on June 9, 2026. The company has recently seen several director changes.
RateGain partners with ZentrumHub. The numbers are missing.
The travel-tech company announced a connectivity partnership but didn't disclose deal terms, revenue impact, or strategic value against its ₹8,833 crore market cap.
Wabag wins first UAE contract with $30-75m Ajman sewage deal
The Indian water-treatment firm lands a design-and-build order in Ajman, its first in the UAE. The contract spans 24 months and includes power generation systems.
Tega's Molycop deal is live, but the growth outlook just got cut.
The $838M acquisition adds heavy debt to Tega's books. Management now sees Molycop growing at 3% in FY27, not the rate it expected.
Jeena Sikho dumps Entero, guides ₹300 cr profit for FY27
The hospital chain ended its exclusive distribution deal after Entero sought extra spending. Management set a ₹300 crore profit floor for next year, up from ₹222 crore in FY26.
Ashapura's earnings call transcript adds no new numbers to the story.
The full Q4 and FY26 discussion on Guinea, costs, and India operations repeats the same points already disclosed in the results filing.
Bata India's earnings call transcript is a routine recap with no new data.
The Q4 FY26 call, held June 3, discussed inventory reduction and raw-material inflation but added nothing to the May 25 results.
Can Fin Homes to raise ₹5,000 cr in debt — 46% of its market cap
The board approved a mix of bonds and mortgage-backed securities, a balance-sheet expansion that dwarfs the company's current equity base. Shareholder approval is still needed.
RailTel lands ₹82 cr Haryana signaling job. It barely moves the needle.
The contract is binding, but at 1.92% of annual revenue, it's a routine addition to RailTel's order book.
Waaree Renewable gets 450MWp solar EPC order from its own subsidiary
Sunsational Power, a wholly-owned subsidiary, is the client. The related-party contract is for a ground-mounted project with two years of O&M.
Viyash's Italian pet-care bid jumps 28% to ₹188 cr
The final price for BioForLife is ₹41 crore above the figure Viyash disclosed earlier this year. The deal remains small against the company's own scale.
Viyash buys Italian vet distributor for €17M
The €16.975M cash deal adds a direct sales platform in Italy's companion animal market. It's a strategic, not a financial, move for the mid-cap.
Indo Count aims for ₹5,500 cr in FY27, with new US business set to double
The textile maker’s record-year bet hinges on scaling a US bedding and brands operation that barely existed two years ago.
MMTC's auditor flags going-concern risk as ministry orders exit from business
The government wants MMTC to prepare a road map to shut down. Its auditor flagged a ₹82.82 crore under-provision and a material uncertainty over the company's future.
Intellect carves out Purple Fabric AI as a standalone unit
The enterprise AI platform serving 45+ clients gets its own CEO and autonomy. No financials were attached to the reorganization.
Intellect Design names new CEO for its AI platform division
Deepak Dastrala takes over Purple Fabric, the flagship AI product for financial institutions. The move is strategic but has no disclosed financial impact.
Black Box wants to double revenue to $2bn by FY30
A five-year plan to reach $2 billion in revenue leans on $700m of future acquisitions and an $800m order backlog that management says provides multi-year visibility.
Kovai Medical's Joint MD Dr. Thavamani Devi dies, leaving no successor
The promoter and hospital leader held her post since 2000. Kovai says the loss is 'irreplaceable' and has not named a replacement.
Alembic takes 45% in new Canadian pharma JV with Difgen Holdings
Alembic Pharmaceuticals is entering the Canadian market via a joint venture but won't say how much it's spending.
Zee's board meets June 10 to approve a share sale.
The company will consider raising funds through equity or convertible securities via a private placement or preferential issue. No size or terms were disclosed.
Fiem is breaking into cars. It just gave its first numbers.
Record FY26 results are old news. The new story is a ₹100-150 crore four-wheeler revenue target for FY27, backed by Mahindra & Mahindra orders and a management reshuffle.
MIDHANI posts record FY26 revenue, commits ₹1,000 cr to modernisation
The defence materials maker logged its highest-ever annual sales and outlined a three-year plan to spend big on downstream capacity.
ASM Technologies lines up ₹500 cr raise, 11% of its market cap
The board approved a fundraising plan that could issue up to ₹500 crore in new equity, a large move for a ₹4,729 crore company. Shareholder nod is next.